Yahoo Finance December 7, 2022
H1

Which data will inform more diverse clinical trials? Will healthcare influencers leave Twitter? How will engaging HCP thought leaders evolve? H1 shares its prognosis.

NEW YORK, Dec. 07, 2022 (GLOBE NEWSWIRE) — H1, the connecting force for global healthcare provider, clinical, science, and research information, today released its predictions for 2023 to help life sciences, pharmaceutical, and healthcare companies understand larger industry trends and dynamics to plan and prepare for the new year.

Access to medicine and healthcare is a basic human right. Access to the best healthcare information is also a basic human right – one that will be more important in the 21st century than ever before. When roughly one-third of all data around the world is generated...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Big Data, Clinical Trials, Provider, Social Media, Technology, Trends
Related Articles:
In-Depth: 2025 Best in KLAS Overall and Category Awards
Employers Reap $190 for Every $100 Invested in Behavioral Health
Report: AI controls growing VC attention in Europe
Calling patients at their home
Affineon Health Raises $5M for AI-Powered Physician Inbox Management

Share This Article